BioTelemetry Inc logo

BEAT - BioTelemetry Inc Share Price

$54.12 -1.2  -2.1%

Last Trade - 17/01/20

Sector
Healthcare
Size
Mid Cap
Market Cap £1.44bn
Enterprise Value £1.54bn
Revenue £329.4m
Position in Universe 1982nd / 6416
Bullish
Bearish
Unlock BEAT Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BEAT Revenue Unlock BEAT Revenue

Net Income

BEAT Net Income Unlock BEAT Revenue

Normalised EPS

BEAT Normalised EPS Unlock BEAT Revenue

PE Ratio Range

BEAT PE Ratio Range Unlock BEAT Revenue

Dividend Yield Range

BEAT Dividend Yield Range Unlock BEAT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BEAT EPS Forecasts Unlock BEAT Revenue
Profile Summary

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The Company operates in three segments: Healthcare, Technology and Research. The Healthcare segment, operating as CardioNet, LLC and Heartcare Corporation of America, Inc., is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. The Research segment, operating as Cardiocore, LLC and VirtualScopics, Inc., is engaged in laboratory services that provide cardiac monitoring, imaging services, scientific consulting and data management services for drug, medical treatment and device trials. The Technology segment, operating as Braemar Manufacturing, LLC, Universal Medical, Inc. and BioTelemetry Belgium BVBA. and BioTelemetry Technology ApS, focuses on the manufacturing, engineering and development of noninvasive cardiac monitors for healthcare companies.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated April 12, 2013
Public Since August 1, 2013
No. of Shareholders: 60
No. of Employees: 1,500
Sector Healthcare
Industry Healthcare Providers & Services
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 33,991,107
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BEAT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BEAT
Upcoming Events for BEAT
Similar to BEAT
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.